Cambridge Investment Research Advisors »

Vaneck Vectors Pharmaceutical etf shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $258k 2.8k 90.62
2023-06-30 $772k 9.8k 78.76
2023-03-31 $510k 6.6k 77.58
2022-12-31 $2.1M 27k 77.73
2022-09-30 $219k 3.3k 67.30
2022-06-30 $309k 4.0k 76.85